drugset / Trial / NCT06461039
A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
NaSequentialOpen-labelTreatment
Summary
This study medicine NNC0487-0111 to improve the treatment options for people living with overweight and obesity or with type 2 diabetes. The purpose of the study is to investigate if NNC0487-0111 affects how effective birth control pills are. Participants will take 1-tablet once daily. The study medicine will taken orally for 18 weeks and then study medicine will be injected with a thin needle in a skin fold in the abdomen for 9 weeks.The study will last for about 35 weeks.
Timeline
- Start
- 2024-06-14
- Primary completion
- 2025-03-16
- Completion
- 2025-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | 150 ug | Oral |
| Subject | NNC0487-0111 | Unknown | — | Subcutaneous |
| Subject | ethinyl estradiol | Small molecule | 30 ug | Oral |
| Background | Acetaminophen | Small molecule | 500 mg | Oral |